Public Health England (PHE) today confirmed that a person in the southwest of England has been diagnosed as having monkeypox, likely contracted after a recent visit to Nigeria.
The United Kingdom documented its first cases of the rare virus last year, in two patients who also likely contracted the disease in Nigeria, plus a case involving a healthcare worker—the first instance of spread of the disease in the country.
Pakistan, Nigeria, the Democratic Republic of the Congo (DRC), and Angola each reported new cases of vaccine-derived polio, according to the latest weekly update today from the Global Polio Eradication Initiative (GPEI), and Pakistan also confirmed cases involving the wild-type virus.
In updates yesterday and today, Saudi Arabia's Ministry of Health (MOH) reported two more MERS-CoV cases, one of them fatal and both from Riyadh.
One of the patients is a 33-year-old man whose contact with camels isn't known. He is not a health worker, and his exposure is listed as primary, meaning he probably didn't contract MERS-CoV (Middle East respiratory syndrome coronavirus) from another patient.
Some parts of the south and central US are among the few hot spots, and flu strains vary by region.
Takeda's dengue vaccine candidate (TAK-003) is safe and effective against dengue virus, according to part 1 of phase 3 clinical trial results published yesterday in the New England Journal of Medicine.
After going 2 days with no new cases, the Democratic Republic of the Congo (DRC) today reported 7 new lab-confirmed cases and 1 additional probable infection, raising the overall outbreak total to 3,282, which includes 118 probable cases, according to the World Health Organization (WHO) online Ebola dashboard.
Health officials are still investigating 447 suspected Ebola cases.
About 94% of H3N2 viruses were the drifted strain, and the vaccine afforded no protection against H3N2.
The Food and Drug Administration (FDA) approved the use single-dose Xofluza (baloxavir marboxil) for patients ages 12 and over who are at high risk for influenza complications. Xofluza should only be administered to patients who have been symptomatic for 48 hours or less.
Yesterday three of the nation's biggest health organizations—the American Lung Association, the American Diabetes Association, and the American Heart Association—recommended that Americans living with chronic health conditions get this year's seasonal influenza vaccine.
In its latest weekly update, the Global Polio Eradication Initiative (GPEI) said today that Pakistan recorded three new cases of wild poliovirus type 1 (WPV1) this week, and the Democratic Republic of the Congo (DRC) and the Central African Republic recorded new cases of vaccine-derived poliovirus type 2 (cVDPV2).
